ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,844,962 | -32.3% | 3,350,000 | -30.9% | 0.05% | -39.5% |
Q3 2022 | $2,726,000 | -8.6% | 4,850,000 | -9.3% | 0.08% | -29.6% |
Q2 2022 | $2,981,000 | -4.0% | 5,350,000 | -10.8% | 0.12% | +13.9% |
Q1 2022 | $3,105,000 | -16.2% | 6,000,000 | -14.3% | 0.10% | -15.8% |
Q4 2021 | $3,705,000 | – | 7,000,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PenderFund Capital Management Ltd. | 29,679,000 | $23,720,000 | 7.42% |
SILVERBACK ASSET MANAGEMENT LLC | 11,750,000 | $6,487,175 | 0.92% |
DCF Advisers, LLC | 1,550,000 | $884,000 | 0.57% |
Context Capital Management, LLC | 14,764 | $8,274,000 | 0.56% |
AGF Investments LLC | 7,000,000 | $3,872,000 | 0.36% |
WHITEBOX ADVISORS LLC | 19,600,000 | $10,682,000 | 0.30% |
Pentwater Capital Management LP | 46,411,000 | $26,134,000 | 0.29% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $11,591,000 | 0.27% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $13,275,000 | 0.24% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 14,900,000 | $8,493,000 | 0.12% |